Abstract
IntroductionDelta-δ-tetrahydrocannabinol and cannabidiol (THC:CBD) oromucosal spray is used as an add-on therapy option for moderate to severe multiple sclerosis (MS) spasticity resistant to other medications. Aims of this study were...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have